Showing results (171-180 of 423) with videos related to
Sort By:
Pageof 43
Clinical Journal of the American Society of Nephrology : CJASN|April 17, 2010
Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysisMin Jun, Hiddo J Lambers Heerspink, Toshiharu Ninomiya, et al.The Cochrane Database of Systematic Reviews|September 25, 2018
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseClement Lo, Tadashi Toyama, Ying Wang, et al.American Heart Journal|July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trialBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.The Cochrane Database of Systematic Reviews|June 1, 2016
Interventions for lowering plasma homocysteine levels in dialysis patientsSagar U Nigwekar, Amy Kang, Sophia Zoungas, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 7, 2016
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysisKevin Quach, Lyubov Lvtvyn, Colin Baigent, et al.Diabetes, Obesity & Metabolism|January 31, 2019
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysisTadashi Toyama, Brendon L Neuen, Min Jun, et al.Nephrology (Carlton, Vic.)|December 23, 2014
Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': the ACTIVE Dialysis StudyMeg J Jardine, L I Zuo, Nicholas A Gray, et al.Kidney International Reports|May 14, 2023
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V Rizk, Brad H Rovin, Hong Zhang, et al.Internal Medicine Journal|January 11, 2025
Risk factors associated with 30-day mortality following COVID-19 infection in patients receiving kidney replacement therapy in Australia and New ZealandPeter Kolovos, Christopher E Davies, Feruza Kholmurodova, et al.Journal of the American Heart Association|December 2, 2021
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS TrialTaha Sen, Jingwei Li, Brendon L Neuen, et al.Pageof 43